Agenus Inc.
Clinical trials sponsored by Agenus Inc., explained in plain language.
-
New drug trial offers hope for advanced melanoma patients out of options
Disease control OngoingThis study is testing an experimental drug called botensilimab, alone and in combination with another drug, for people with advanced skin cancer (melanoma) that has continued to grow despite previous immunotherapy treatments. The goal is to see if the new treatment can shrink tum…
Phase: PHASE2 • Sponsor: Agenus Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New hope for tough pancreatic cancer cases: immune drug added to chemo
Disease control OngoingThis study is testing whether adding an immunotherapy drug called botensilimab to standard chemotherapy works better than chemotherapy alone for people with metastatic pancreatic cancer that has worsened after initial treatment. About 81 participants will be randomly assigned to …
Phase: PHASE2 • Sponsor: Agenus Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New immune weapons tested against tough colon cancers
Disease control OngoingThis study is testing whether new immunotherapy drugs called botensilimab and balstilimab can help control advanced colon cancer that has spread and stopped responding to standard chemotherapy. The trial will compare these drugs given alone or together against current standard tr…
Phase: PHASE2 • Sponsor: Agenus Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC